Loss of membranous expression of the intracellular domain of EpCAM is a frequent event and predicts poor survival in patients with pancreatic cancer
出版年份 2013 全文链接
标题
Loss of membranous expression of the intracellular domain of EpCAM is a frequent event and predicts poor survival in patients with pancreatic cancer
作者
关键词
-
出版物
HISTOPATHOLOGY
Volume 64, Issue 5, Pages 683-692
出版商
Wiley
发表日期
2013-10-12
DOI
10.1111/his.12307
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines
- (2012) Agnieszka Martowicz et al. BMC CANCER
- Documenting the Natural History of Patients With Resected Stage II Adenocarcinoma of the Colon After Random Assignment to Adjuvant Treatment With Edrecolomab or Observation: Results From CALGB 9581
- (2011) Donna Niedzwiecki et al. JOURNAL OF CLINICAL ONCOLOGY
- EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis
- (2011) Gilbert Spizzo et al. JOURNAL OF CLINICAL PATHOLOGY
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ep-CAM is a significant prognostic factor in pancreatic cancer patients by suppressing cell activity
- (2011) H Akita et al. ONCOGENE
- Impact of the EpCAM expression on biochemical recurrence-free survival in clinically localized prostate cancer
- (2011) Goran Benko et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- EpCAM nuclear localization identifies aggressive Thyroid Cancer and is a marker for poor prognosis
- (2010) Ranju Ralhan et al. BMC CANCER
- The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial
- (2010) Markus M. Heiss et al. INTERNATIONAL JOURNAL OF CANCER
- Nuclear and Cytoplasmic Accumulation of Ep-ICD Is Frequently Detected in Human Epithelial Cancers
- (2010) Ranju Ralhan et al. PLoS One
- An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer
- (2009) M. Schmidt et al. ANNALS OF ONCOLOGY
- EpCAM: Another Surface-to-Nucleus Missile
- (2009) Graham Carpenter et al. CANCER CELL
- Nuclear signalling by tumour-associated antigen EpCAM
- (2009) Dorothea Maetzel et al. NATURE CELL BIOLOGY
- Prognostic Effect of Epithelial Cell Adhesion Molecule Overexpression in Untreated Node-Negative Breast Cancer
- (2008) M. Schmidt et al. CLINICAL CANCER RESEARCH
- A Decade of Tissue Microarrays: Progress in the Discovery and Validation of Cancer Biomarkers
- (2008) Robert L. Camp et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started